Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Topics Sessions Videos Previous meetings

Posters by Session

Select Session

Thumbnail for The Effect of Bezuclastinib on the Pathobiology of Mastocytosis: Changes in Bone Marrow Mast Cells, Tryptase, and KIT p.D816V Variant Allele Frequency From the Pivotal Summit Trial

MPN - 1154

The Effect of Bezuclastinib on the Pathobiology of Mastocytosis: Changes in Bone Marrow Mast Cells, Tryptase, and KIT p.D816V Variant Allele Frequency From the Pivotal Summit Trial

Dana Longo

Poster Presenter: Dana Longo

Thumbnail for The Effect of Bezuclastinib on the Pathobiology of Advanced Systemic Mastocytosis: Results from the Pivotal Apex Trial

MPN - 1161

The Effect of Bezuclastinib on the Pathobiology of Advanced Systemic Mastocytosis: Results from the Pivotal Apex Trial

Tram Le

Poster Presenter: Tram Le

Previous 1...127 128 129 130 131 132 133...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Efficacy and Safety of Bezuclastinib in Patients With Advanced Systemic Mastocytosis: Results From the Apex Study

MPN - 1187

Efficacy and Safety of Bezuclastinib in Patients With Advanced Systemic Mastocytosis: Results From the Apex Study

Cristina Papayannis

Poster Presenter: Cristina Papayannis

Thumbnail for RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

MPN - 120

RALLY-MF: Initial Efficacy of a Phase 2 Study of DISC-0974, an Anti-Hemojuvelin Antibody, to Treat Anemia in Myelofibrosis

Naseema Gangat

Poster Presenter: Naseema Gangat

Thumbnail for Real-World Use of Pacritinib in Myelofibrosis: Results From the TriNetX Analysis on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Platelets =50Χ109/L at Initiation (TRIPAC)

MPN - 1200

Real-World Use of Pacritinib in Myelofibrosis: Results From the TriNetX Analysis on Patient Characteristics, Treatment Patterns, and Outcomes in Patients With Platelets =50Χ109/L at Initiation (TRIPAC)

Faizan Sattar

Poster Presenter: Faizan Sattar

Thumbnail for Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

MPN - 1206

Discovery and Characterization of DMR-001, an Fc-Null, Half-Life-Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

Mark Benton

Poster Presenter: Mark Benton

Thumbnail for Arterial and Venous Thrombosis in Myeloproliferative Neoplasm Hospitalizations: Distinct Associations With Mortality and Resource Utilization

MPN - 1235

Arterial and Venous Thrombosis in Myeloproliferative Neoplasm Hospitalizations: Distinct Associations With Mortality and Resource Utilization

Priyanka Nagdev

Poster Presenter: Priyanka Nagdev

Thumbnail for Expanded Results From the Phase 2 Summit Trial: Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis

MPN - 1268

Expanded Results From the Phase 2 Summit Trial: Bezuclastinib in Adults With Nonadvanced Systemic Mastocytosis

Pankit J Vachhani

Poster Presenter: Pankit J Vachhani

Thumbnail for KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

MPN - 1280

KRAS Mutations in Histiocytic Neoplasms: Mutation Spectrum and Response to MEK Inhibition

Dongni Yi

Poster Presenter: Dongni Yi

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors